Innovation
fueled by Passion

While supporting existing assets and developing new indications to address unmet needs, our drug development program is focused on two therapeutic areas: gastroenterology and rheumatology.

Our new strategic plan deals with next decades challenges in healthcare, leveraging opportunities in precision medicine, maximizing existing competencies in microbiome, acquiring new assets in late stage development.
We are partnering with other organizations to exploit new opportunities through big data, new technologies, and patient engagement projects.